Tarsus Pharmaceuticals: Pay

Tarsus Pharmaceuticals paid its 5 named executives $17.3M in total in FY2025 (Dec). CEO Bobak Azamian, M.D., Ph.D. was paid $6.6M of that.

Pay$100 in the stock at the end of FY21 → $364
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Bobak Azamian, M.D., Ph.D.President, Chief Executive Officer and Board Chairman
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)Not disclosed
FY2022 (Dec)Not disclosed
4 years
Aziz MottiwalaChief Commercial Officer
FY2025 (Dec)
FY2024 (Dec)
2 years
Jeffrey FarrowChief Financial Officer and Chief Strategy Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)Not disclosed
3 years
Seshadri Neervannan, Ph.D.Chief Operating Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)Not disclosed
3 years
Bryan Wahl, M.D., J.D.General Counsel
FY2025 (Dec)
1 year

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 4 peers with pay on file was $13.0M. The CEO of Tarsus Pharmaceuticals was paid $6.6M, 49% below the median.

  1. 1Ocular Therapeutix
  2. 2Supernus Pharmaceuticals
  3. 3Mirum Pharmaceuticals
  4. 4Arcutis Biotherapeutics
  5. 5Tarsus Pharmaceuticals
  6. 6Ardelyx, Inc.Not disclosed
  7. 7Aurinia Pharmaceuticals, Inc.Not disclosed
  8. 8Catalyst Pharmaceuticals, Inc.Not disclosed
  9. 9Day One Biopharmaceuticals, Inc.Not disclosed
  10. 10Dynavax Technologies Corp.Not disclosed
  11. 11Evolus, Inc.Not disclosed
  12. 12Harrow, Inc.Not disclosed
  13. 13Ironwood Pharmaceuticals, Inc.Not disclosed
  14. 14Kiniksa Pharmaceuticals, Ltd.Not disclosed
  15. 15MannkindNot disclosed
  16. 16Rhythm PharmaceuticalsNot disclosed
  17. 17SpringWorks Therapeutics, Inc.Not disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.